Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

Heart Pump Device Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21278

Download Sample Report
Published On

June 2021

Total pages

126

About the Report

HEART PUMP DEVICES ARE ALSO KNOWN AS VENTRICULAR ASSIST DEVICES (VAD), IS AN IMPLANTABLE MECHANICAL PUMP WHICH HELPS PUMP BLOOD FROM THE LOWER CHAMBERS OF THE HEART (VENTRICLES) TO THE REST OF THE BODY. THIS DEVICE IS USED IN PEOPLE WITH WEAKENED HEARTS OR HEART FAILURE. HEART PUMPS ARE MOST FREQUENTLY PLACED ON THE LEFT SIDE OF THE HEART AND ARE KNOWN AS LEFT VENTRICULAR ASSIST DEVICE (LVAD). A PERSON CAN HAVE A HEART PUMP IMPLANTED WHILE THEY ARE WAITING FOR A HEART TRANSPLANT OR WHILE ONE'S HEART IS RECOVERING, AS HEART PUMPS CAN SUPPORT THE HEART WHILE THEY ARE RECOVERING. HEART PUMPS CAN ALSO BE IMPLANTED FOR LONG TERM TREATMENTS FOR PATIENTS WITH HEART FAILURE AND ARE NOT ELIGIBLE FOR HEART TRANSPLANTS. HEART PUMP IMPLANTATIONS REQUIRE AN OPEN-HEART SURGERY AND CAN HAVE SERIOUS RISKS. HOWEVER, IN THE CASES OF SEVERE HEART FAILURES, THESE DEVICES CAN BE LIFESAVING.

BASED ON PRODUCT, THE HEART PUMP DEVICES MARKET IS SEGMENTED INTO VENTRICULAR ASSIST DEVICES (VADS), INTRA-AORTIC BALLOON PUMPS (IABPS) AND TOTAL ARTIFICIAL HEART (TAH). THE VENTRICULAR ASSIST DEVICES SEGMENT WAS VALUED AT USD XX MILLION IN 2020 AND IS LIKELY TO REACH USD XX MILLION BY 2027 GROWING AT A CAGR OF XX% FROM 2021-2027. BASED ON TYPE, THE HEART PUMP DEVICES MARKET IS BIFURCATED INTO IMPLANTABLE AND EXTRACORPOREAL HEART PUMP DEVICES. THE IMPLANTABLE HEART PUMP DEVICES ACCOUNTED FOR A MARKET VALUATION OF USD XX MILLION IN 2020 AND IS EXPECTED TO REACH USD XX MILLION BY THE YEAR 2027, AT A CAGR OF XX% OVER THE ANALYSED PERIOD.

BASED ON THERAPY, THE HEART PUMP DEVICES MARKET IS SEGMENTED INTO BRIDGE-TO-TRANSPLANT (BTT), BRIDGE-TO-CANDIDACY (BTC), DESTINATION THERAPY (DT) AND OTHER THERAPIES. BRIDGE-TO-TRANSPLANT (BTT) THERAPY IS EXPECTED TO WITNESS HIGHEST CAGR GROWTH DURING THE FORECAST PERIOD. BRIDGE-TO-TRANSPLANT ACCOUNTED FOR A MARKET VALUATION OF USD XX MILLION IN 2020 AND IS EXPECTED TO REACH USD XX MILLION BY THE YEAR 2027, AT A CAGR OF XX% OVER THE ANALYSED PERIOD.

FOR A BETTER UNDERSTANDING OF THE MARKET ADOPTION OF THE HEART PUMP DEVICE MARKET, THE MARKET IS ANALYSED FOR MAJOR REGIONS INCLUDING NORTH AMERICA (UNITED STATES, CANADA, AND REST OF NORTH AMERICA), EUROPE (GERMANY, FRANCE, ITALY, SPAIN, UNITED KINGDOM AND REST OF EUROPE), ASIA-PACIFIC (CHINA, JAPAN, INDIA, AUSTRALIA, AND REST OF APAC), AND REST OF WORLD. NORTH AMERICA CONSTITUTES A MAJOR MARKET FOR THE HEART PUMP DEVICE MARKET INDUSTRY AND GENERATED REVENUE OF USD XX MILLION IN 2020, OWING TO THE PRESENCE OF WELL-ESTABLISHED PLAYERS IN THE REGION, RISING INVESTMENT BY THE COMPANIES, ETC. SOME OF THE MAJOR PLAYERS OPERATING IN THE MARKET ABBOTT LABORATORIES, ABIOMED, MEDTRONIC, TELEFLEX INCORPORATED, SYNCARDIA SYSTEMS, FRESENIUS MEDICAL CARE AG & CO. KGAA, GETINGE, CARDIACASSIST, INC., BERLIN HEART, JARVIK HEART, INC. SEVERAL M&A'S ALONG WITH PARTNERSHIPS HAVE BEEN UNDERTAKEN BY THESE PLAYERS TO BOOST THEIR PRESENCE IN DIFFERENT REGIONS.

HEART PUMP DEVICE MARKET WAS VALUED AT USD 1.7 BILLION IN 2020 AND IS PROJECTED TO EXPAND SIGNIFICANTLY WITH A CAGR OF 18.9% FROM 2021-2027F TO USD 6 BILLION IN 2027. THE HEART PUMP DEVICE MARKET IS EXPECTED TO WITNESS A BOOST ON ACCOUNT OF THE GROWING PREVALENCE OF CARDIOVASCULAR DISEASES.

Scope of the Report

Products

Heart Pump Devices are also known as Ventricular Assist Devices (VAD), is an implantable mechanical pump which helps pump blood from the lower chambers of the heart (ventricles) to the rest of the body.

Companies

ABBOTT LABORATORIES

ABIOMED

MEDTRONIC

TELEFLEX INCORPORATED

SYNCARDIA SYSTEMS

FRESENIUS MEDICAL CARE AG & CO. KGAA

GETINGE

CARDIACASSIST

INC.

BERLIN HEART

JARVIK HEART

INC.

Table of Contents

1 MARKET INTRODUCTION

1.1. MARKET DEFINITIONS

1.2. OBJECTIVE OF THE STUDY

1.3. LIMITATION

1.4. STAKE HOLDERS

1.5. CURRENCY USED IN REPORT

1.6. SCOPE OF THE HEART PUMP DEVICE MARKET STUDY

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. RESEARCH METHODOLOGY FOR THE HEART PUMP DEVICE MARKET

2.1.1. MAIN OBJECTIVE OF THE HEART PUMP DEVICE MARKET

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY PRODUCT

6.1. VENTRICULAR ASSIST DEVICES (VADS)

6.1.1. LEFT VENTRICULAR ASSIST DEVICES (LVADS)

6.1.2. RIGHT VENTRICULAR ASSIST DEVICES (RVADS)

6.1.3. BI-VENTRICULAR ASSIST DEVICES (BIVADS)

6.1.4. PERCUTANEOUS VENTRICULAR ASSIST DEVICES (PVADS)

6.2. INTRA-AORTIC BALLOON PUMPS (IABPS)

6.3. TOTAL ARTIFICIAL HEART (TAH)

7 MARKET INSIGHTS BY TYPE

7.1. IMPLANTABLE HEART PUMP DEVICES

7.2. EXTRACORPOREAL HEART PUMP DEVICES

8 MARKET INSIGHTS BY THERAPY

8.1. BRIDGE-TO-TRANSPLANT (BTT)

8.2. BRIDGE-TO-CANDIDANCY (BTC)

8.3. DESTINATION THERAPY (DT)

8.4. OTHER THERAPIES

9 MARKET INSIGHTS BY REGION

9.1. NORTH AMERICA HEART PUMP DEVICE MARKET

9.1.1. UNITED STATES

9.1.2. CANADA

9.1.3. REST OF NORTH AMERICA

9.2. EUROPE HEART PUMP DEVICE MARKET

9.2.1. UNITED KINGDOM

9.2.2. GERMANY

9.2.3. FRANCE

9.2.4. SPAIN

9.2.5. ITALY

9.2.6. REST OF EUROPE

9.3. ASIA-PACIFIC HEART PUMP DEVICE MARKET

9.3.1. CHINA

9.3.2. JAPAN

9.3.3. INDIA

9.3.4. AUSTRALIA

9.3.5. REST OF ASIA-PACIFIC

9.4. REST OF THE WORLD HEART PUMP DEVICE MARKET

10 LEGAL AND REGULATORY FRAMEWORK

11 DEMAND AND SUPPLY SIDE ANALYSIS

11.1. DEMAND SIDE ANALYSIS

11.2. SUPPLY SIDE ANALYSIS

11.2.1. TOP PRODUCT LAUNCHES

11.2.2. TOP BUSINESS PARTNERSHIPS

11.2.3. TOP BUSINESS EXPANSIONS, INVESTMENTS AND DIVESTITURES

11.2.4. TOP MERGER AND ACQUISITIONS

12 VALUE CHAIN ANALYSIS

13 HEART PUMP DEVICE MARKET TRENDS & INSIGHTS

14 HEART PUMP DEVICE MARKET DYNAMICS

14.1. DRIVERS

14.2. CHALLENGES

14.3. IMPACT ANALYSIS

14.4. OPPORTUNITY

15 COMPETITIVE SCENARIO

15.1. HEART PUMP DEVICE MARKET SHARE, BY COMPANY 2020

16 COMPANY PROFILED

16.1. ABBOTT LABORATORIES

16.2. ABIOMED

16.3. MEDTRONIC

16.4. TELEFLEX INCORPORATED

16.5. SYNCARDIA SYSTEMS

16.6. FRESENIUS MEDICAL CARE AG & CO. KGAA

16.7. GETINGE

16.8. CARDIACASSIST, INC.

16.9. BERLIN HEART

16.10. JARVIK HEART, INC.

17 DISCLAIMER

Research Methodology

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022